Friday, October 31, 2014 9:26:27 AM
1) You did again not provide a PPHM or official (such as SEC) document but a posters document on this board. But it is authentic, because now that you gave me a reference here is the original on the PPHM web-site in 2007 Peregrine Pharmaceuticals Enters Into Development Collaboration with Dios Therapeutics
Where was this PR in your first post on the subject?
2) Here this includes PPHM summary of the events of Q1 & Q2 of 2007 (period in which they would have issued a PR related to DIOS).
PEREGRINE PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR FISCAL YEAR 2007. Notice how this SEC listing only dates from "TUSTIN, Calif., July 11, 2007" or 1 month and 11 days after May 31th 2007.
You would think it would be in the MAY 2007 lists, given the numbers glued on that deal. But it isn't.
And here is the EDGAR listing of that period. Hmmm, PPHMs PR about Dios is not in that list either.
And this is the name of the IR that issued the DIOS PR:
So now we can possible making SOME conclusion on all this DIOS stuff.
1) We have a PR about a DIOS deal FROM PPHM and on PPHM's web-site.
2) We have NO mention on the deal in the FY2007 a month later
3) We have no SEC listing of the PR
4) We have seen NO revenue of DIOS in the quarterlies
So PPHM entered a deal with DIOS and the deal disappeared completely as if it never existed EXCEPT it was written about on MAY 1st 2007 - month before the PR of PPHM, and mentioned once by Reuters 1 min after PPHM issued the PR.
And so we conclude this must have been a hoax, a scam, a sham and that there is NO explanation why this happened.
At the most this gave an artificial kick to the PPS on MAY 31th 2007 because without that PR there would not have been that peek above 1.40$ to close at 1.39$ So As I already conceded in previous posts on the topic we can KEEP saying that PPHM timed its PRs well and that they were aiming to enter the Russel 2000 thanks to them. And that would have been good for them and share holders but it didn't work.
So the irregularity here would be that the PR wasn't SEC listed (as it should be). And we know the deal was CONDITIONAL upon DIOS providing that anti-body information and if THEY never did then PPHM could never produce and the contract didn't activate as the terms learn us and PPHM couldn't generate value out of it for the shareholders.
But I still see no hoax, scam, sham or so.
Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.
Recent CDMO News
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:33:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:32:11 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM